The team of Dr. Katerina Akassoglou at Gladstone Institutes and UCSF studied the gene signature of pathogenic innate immune cells in the CNS.
Seneca Biopharma is working with the FDA to finalize the design of a phase 3 trial of neural stem cell NSI-566 for the treatment of ALS.
By contributing to changes in metabolism, immunity, and neurophysiology, alterations in the gut microbiome influence developmental processes in the brain and are potentially involved in Autism Spectrum Disorder pathogenesis.
Chronic Adolescent Stress Found to Potentiate Sex-specific Immune Responses that May Contribute to Mood Disorders during Adulthood
Researchers from Emory University investigated whether chronic adolescent stress (CAS) modulates immune responses within the brain to promote depression and anxiety during adulthood and suggest that males and females are uniquely affected by CAS.
Genetic Variants of Receptor Detecting Inflammation and Tissue Damage May Increase Susceptibility for Depression
Genetic variants of an innate immune receptor that detects inflammation and tissue damage have been associated with HADS depression severity scores and susceptibility for depression by a group of Hungarian researchers.